Meningioma with rhabdoid features: Pathologic findings in dogs

Alexandru-Flaviu Tabaran1,2, Anibal G Armien1,3, G Elizabeth Pluhar1

  • 1University of Minnesota, St. Paul, MN.

Insights

Canine meningiomas can exhibit rhabdoid morphology, mimicking human tumors. Ultrastructural analysis is crucial for accurate diagnosis, revealing diverse cellular differentiations beyond rhabdoid features.

Area of Science:

  • Veterinary Pathology
  • Comparative Oncology
  • Neoplasia

Background:

  • Rhabdoid meningioma is a rare human meningeal neoplasm.
  • Canine meningiomas are common intracranial tumors, but rhabdoid variants are poorly characterized.
  • This study investigates canine meningiomas with rhabdoid features.

Purpose of the Study:

  • To describe the clinical, pathological, and ultrastructural characteristics of canine meningiomas with rhabdoid features.
  • To compare these findings with human rhabdoid meningiomas.
  • To determine the diagnostic utility of ultrastructural examination in these cases.

Main Methods:

  • Histopathological examination of tumor biopsies from 4 canine cases.
  • Immunohistochemical analysis for vimentin, melan A, S100 protein, cytokeratin, and glial fibrillary acidic protein (GFAP).
  • Ultrastructural evaluation using transmission electron microscopy.

Main Results:

  • Tumors consisted of discohesive cells with eosinophilic cytoplasm and hyaline-like inclusions.
  • Immunohistochemistry showed vimentin positivity in all cases, variable cytokeratin, and focal GFAP positivity in one case.
  • Ultrastructural findings varied: prominent intermediate filament whorls in one case, maze-like cell processes in two, and oncocytic differentiation in one, challenging the initial rhabdoid diagnosis.

Conclusions:

  • Rhabdoid morphology in canine meningiomas can arise from different tumor types.
  • Ultrastructural examination is essential for differentiating true rhabdoid meningioma from other neoplasms with similar light microscopic appearances.
  • These findings aid in comparative pathology and understanding meningioma heterogeneity.